Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in PCD pharma franchise in Hyderabad

Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in pharma manufacturing company in Pune

Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in respiratory care pharma franchise in India

Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in PCD pharma suppliers in Delhi

Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in pharma franchise in Mumbai
Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in pharma export companies in India

Home/Products /levosalbutamol-0-point-25mg-ambroxol-7-point-5mg-guaifenesin-12-point-5mg-drop

Cufsniff LS Drop

Composition : Ambroxol (7.5mg) + Levosalbutamol (0.25mg) + Guaifenesin (12.5mg)

Dosage Form : Drop

Packaging Type : with Carton and Dropper

Packaging : 15 ml

Price : ₹87/-

Cufsniff LS Drop combines Ambroxol (7.5mg)Levosalbutamol (0.25mg), and Guaifenesin (12.5mg) in a single formulation, designed to provide effective relief from respiratory conditions associated with mucus overproduction, coughing, and airway obstruction. Ambroxol acts as a mucolytic agent, thinning and loosening mucus in the airways, making it easier to expel. Levosalbutamol is a bronchodilator that relaxes the airway muscles, improving airflow and easing breathing difficulties. Guaifenesin works as an expectorant, promoting the clearance of mucus from the respiratory tract. Together, these components ensure efficient relief from cough and congestion while improving respiratory comfort.

Read More

About the Product

Cufsniff LS Drop combines Ambroxol (7.5mg)Levosalbutamol (0.25mg), and Guaifenesin (12.5mg) in a single formulation, designed to provide effective relief from respiratory conditions associated with mucus overproduction, coughing, and airway obstruction. Ambroxol acts as a mucolytic agent, thinning and loosening mucus in the airways, making it easier to expel. Levosalbutamol is a bronchodilator that relaxes the airway muscles, improving airflow and easing breathing difficulties. Guaifenesin works as an expectorant, promoting the clearance of mucus from the respiratory tract. Together, these components ensure efficient relief from cough and congestion while improving respiratory comfort.

Cufsniff LS Drop is generally well-tolerated. However, some individuals may experience mild side effects such as nausea, dizziness, headache, or dry mouth. In rare cases, allergic reactions such as rash, itching, or swelling may occur. If any severe side effects or allergic reactions appear, stop the medication immediately and consult a healthcare provider.

Cufsniff LS Drop is indicated for the relief of cough, mucus congestion, and difficulty in breathing due to conditions like bronchitis, asthma, and other respiratory tract infections. It helps in clearing mucus from the airways, easing coughing, and improving overall respiratory health.

This product is intended for short-term use. If symptoms persist or worsen, consult a healthcare professional. Not suitable for children under 2 years unless directed by a physician. Individuals with a history of heart disease or high blood pressure should consult a healthcare provider before use.

Store in a cool, dry place, away from direct sunlight. Keep the bottle tightly closed and out of reach of children. Ensure proper storage to maintain the efficacy of the product.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation